Correction to: British Journal of Cancer (2009) 101, 441–451; doi:10.1038/sj.bjc.6605186
Owing to an error during the final correction of this paper, panels E and F in Figure 4 were incorrectly typeset, resulting in the loss of part of panel 4E. The publishers apologise for this mistake.
Differences in PARP activity and in viability between WT and MLH1-depleted cells. (E) WT and M1 cells were treated with 2 mM MNU, either alone or in combination with 30 mM DPQ or 10 mM Boc-D-FMK; as a control, cells treated with camptothecin were assayed at 72 h; values represent the mean of three samples ±s.d.; ***P<0.001; *P<0.05; NS, not significant. (F) Clonogenic assays in response to 2 mM MNU, 30 mM DPQ or a combination of the two were carried out on the indicated cell lines with two plates per cell line; error bars indicate ±s.d. values. The assay was carried out three times for the fibroblasts (WT and M1), with representative results shown, and once for the controls (HCT116 and HCT116þchr3).
The correct panels 4E and 4F are reproduced below:
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6605186
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
McDaid, J., Loughery, J., Dunne, P. et al. Erratum: MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea. Br J Cancer 102, 1080 (2010). https://doi.org/10.1038/sj.bjc.6605615
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6605615
